資料2-2 令和5年度業務実績評価書(案) (101 ページ)
出典
公開元URL | https://www.mhlw.go.jp/stf/newpage_41369.html |
出典情報 | 独立行政法人評価に関する有識者会議 国立病院WG(第12回 7/30)《厚生労働省》 |
ページ画像
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
中期目標
中期計画
年度計画
主な評価指標
法人の業務実績・自己評価
業務実績
controlled trial. Lancet Neurol. 2020 Apr;19(4):298-306.
〇 Hiromichi Wada , MD, PhD; Masahiro Suzuki , MD, PhD; Morihiro Matsuda, MD,
PhD; Yoichi Ajiro , MD, PhD;Tsuyoshi Shinozaki , MD, PhD; Satoru Sakagami, MD,
PhD; Kazuya Yonezawa, MD, PhD; Masatoshi Shimizu, MD, PhD;Junichi Funada, MD,
PhD; Takashi Takenaka, MD, PhD; Yukiko Morita, MD, PhD; Toshihiro Nakamura, MD,
PhD;Kazuteru Fujimoto, MD, PhD; Hiromi Matsubara, MD, PhD; Toru Kato, MD, PhD;
Takashi Unoki, MD;Daisuke Takagi, MD; Kyohma Wada, MD; Miyaka Wada; Moritake
Iguchi, MD, PhD; Nobutoyo Masunaga, MD;Mitsuru Ishii, MD; Hajime Yamakage, ME;
Toru Kusakabe, MD, PhD; Akihiro Yasoda, MD, PhD; Akira Shimatsu, MD,
PhD;Kazuhiko Kotani, MD, PhD; Noriko Satoh-Asahara, MD, PhD; Mitsuru Abe, MD,
PhD; Masaharu Akao, MD, PhD;Koji Hasegawa, MD, PhD; for the ANOX Study
Investigators. Impact of Smoking Status on Growth Differentiation Factor 15 and
Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX
Study. J Am Heart Assoc. 2020 Nov 17;9(22):e018217.
〇 Takahiko Yasuda, Masashi Sanada, Masahito Kawazu, Shinya Kojima, Shinobu
Tsuzuki, Hiroo Ueno, Eisuke Iwamoto,Yuka Iijima-Yamashita, Tomomi Yamada,
Takashi Kanamori, Rieko Nishimura, Yachiyo Kuwatsuka, Satoru Takada,Masatsugu
Tanaka, Shuichi Ota, Nobuaki Dobashi, Etsuko Yamazaki, Asao Hirose, Tohru
Murayama, Masahiko Sumi,Shinya Sato, Naoyuki Tange, Yukinori Nakamura, Yuna
Katsuoka, Emiko Sakaida, Toyotaka Kawamata, Hiroatsu Iida,Yuichi Shiraishi,
Yasuhito Nannya, Seishi Ogawa, Masafumi Taniwaki, Norio Asou, Yoshihiro Hatta,
Hitoshi Kiyoi,Itaru Matsumura, Keizo Horibe, Hiroyuki Mano, Tomoki Naoe, Yasushi
Miyazaki, and Fumihiko Hayakawa. Two novel high-risk adult B-cell acute
lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2
mutations. Blood. 2022 Mar 24;139(12):1850-1862.
〇 Maho Suzukawa , Ken Ohta , Yuma Fukutomi , Hiroya Hashimoto ,Takeo Endo ,
Masahiro Abe , Yosuke Kamide , Makoto Yoshida , Yoshihiro Kikuchi ,Toshiyuki
Kita , Kenji Chibana , Yasushi Tanimoto , Kentaro Hyodo , Shohei Takata ,Toshiya
Inui , Masahide Yasui , Yoshinori Harada , Toshio Sato , Yumi
Sakakibara ,Yoshiaki Minakata , Yoshikazu Inoue , Shinji Tamaki , Tsutomu
Shinohara ,Kazutaka Takami , Motofumi Tsubakihara , Masahide Oki , Kentaro
Wakamatsu ,Masahide Horiba , Gen Ideura , Koko Hidaka , Akiko M. Saito ,Nobuyuki
Kobayashi , Masami Taniguchi. Classifications of moderate to severe asthma
phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study
in Japan (NHOM Asthma Study). Allergol Int. 2023 Jan;72(1):63-74.
100
主務大臣による評価
自己評価
評定